In this context, several authors have postulated that CAIX may provide a more reliable marker of hypoxia in tumours than HIF-1α, given its strong regulation by hypoxia-related processes and long half-life after hypoxic induction, allowing for the identification of chronically hypoxic tumour areas [43]. This evidence concerns the gene HIF1A and neoplasm.